NCLT allows Shivinder to withdraw plea against elder brother Malvinder Singh Medical Dialogues Bureau15 Sept 2018 12:48 PM ISTNew Delhi: Former Fortis Healthcare promoter Shivinder Mohan Singh said that the NCLT allowed former Fortis Healthcare promoter Shivinder Mohan Singh...
Alembic Pharma gets USFDA nod for Alogliptin and Metformin tablet Medical Dialogues Bureau15 Sept 2018 12:47 PM ISTAlogliptin and Metformin Hydrochloride tablets got tentative market approval from USFDA. It is used as the diabetes drug.New Delhi: Alembic...
USFDA completes inspection of Nagpur facility, no observation issued: Lupin Medical Dialogues Bureau15 Sept 2018 9:41 AM ISTNew Delhi: Drug firm Lupin said the US health regulator has completed an inspection of its Nagpur facility in Maharashtra without any observation. The...
FDA approves AstraZeneca drug, Lumoxiti for a type of Leukaemia Medical Dialogues Bureau14 Sept 2018 3:15 PM ISTAstraZeneca got the green signal to treat leukaemia cancer approved by Food Drug Association (FDA). Hairy cell leukaemia is a rare form of blood...
EU investigating second impurity in Valsartan Medical Dialogues Bureau14 Sept 2018 3:05 PM ISTFRANKFURT: Europe's drugs regulator is looking into another potentially cancer-causing substance in a common blood pressure and heart drug produced in...
Zydus Cadila gets USFDA nod to market Risedronate drug to treat osteoporosis Medical Dialogues Bureau14 Sept 2018 2:55 PM ISTRisedronate tablets are used to treat Paget's disease of bone. Risedronate is in a class of medications called bisphosphonates. Risedronate alters...
Shivinder to withdraw petition in NCLT against elder brother Malvinder on mother's advice Medical Dialogues Bureau14 Sept 2018 2:01 PM ISTNew Delhi: Former Fortis Healthcare promoter Shivinder Mohan Singh said he has decided to withdraw his petition in NCLT against elder brother...
Lupin gets market approval of Atovaquone oral suspension By USFDA Medical Dialogues Bureau13 Sept 2018 2:06 PM ISTAtovaquone oral suspension used for prevention and treatment of a type of pneumonia.New Delhi: Drug firm Lupin said it has received a approval from...
Merck KGaA, Pfizer develop Bavencio immuno-drug to alleviate kidney cancer Medical Dialogues Bureau13 Sept 2018 2:03 PM ISTFRANKFURT: Merck KGaA said that its immunotherapy Bavencio, jointly developed with Pfizer, delayed the progression of kidney cancer when used in...
Foamix Pharmaceutical acne drug meets Goal in late stage trial Medical Dialogues Bureau13 Sept 2018 2:02 PM ISTFoamix Pharmaceutical recently announced that its drug for treating moderate-to-severe acne has met the main goals of its third late-stage study....
Alcon, Eye Care Unit of Novartis picks Geneva over Texas for new HQ Medical Dialogues Bureau13 Sept 2018 9:21 AM ISTZURICH: The headquarters of Alcon, the eye care unit of Novartis which will be spun off to shareholders in 2019, will move from the division's...
Sun Pharma: USFDA Scrutinizes Mohali plant in Punjab Medical Dialogues Bureau12 Sept 2018 1:43 PM ISTNew Delhi: Drug major Sun Pharmaceutical Industries said the US health regulator is conducting an inspection of its Mohali facility in Punjab. The...